Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients
- 1 September 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (3), 442-450
- https://doi.org/10.1016/0002-9343(84)90100-1
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Therapeutic Granulocyte Transfusions for Documented InfectionsAnnals of Internal Medicine, 1982
- Staphylococcus epidermidis: An Increasing Cause of Infection in Patients with GranulocytopeniaAnnals of Internal Medicine, 1982
- Bacteremias and Fungemias in Oncologic Patients With Central Venous CathetersArchives of Internal Medicine, 1982
- Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescensAntimicrobial Agents and Chemotherapy, 1981
- Piperacillin therapy for serious bacterial infectionsThe American Journal of Medicine, 1980
- Improved prognosis for granulocytopenic patients with gram-negative bacteremiaThe American Journal of Medicine, 1980
- Comparative in vitro activity of moxalactam (LY127935), other beta-lactam antibiotics, and aminoglycosidesCurrent Microbiology, 1980
- Infectious Complications of Human Bone Marrow TransplantationMedicine, 1979
- In Vitro Studies of Piperacillin, a New Semisynthetic PenicillinAntimicrobial Agents and Chemotherapy, 1978
- 125I-Radioimmunoassay of amikacin and comparison with a microbioassay.The Journal of Antibiotics, 1976